Aardvark Therapeutics GAAP EPS of -$0.66 beats by $0.22
Aardvark Therapeutics (AARD) Q2 earnings: GAAP EPS -$0.66 beat, cash $73.9M, runway into late 2027.
What it means
- What to watch: The headline hangs on one number ($0.66) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $AARD -23.02% in the latest session.
- Timing: It landed after the closing bell, so the session change beside it was locked in before the story existed. The next session is the first that could react.
Where the stock stands
$AARD last changed hands at $1.07, -23.02% on the session, 94% below its 52-week high of $16.60 and 15% above its low of $0.93 — within a tenth of its 52-week low. Over the year it has ranged 1685% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $AARD page.
How much coverage it is getting
Nothing else on $AARD in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$AARD earnings in 17 days. These were on the calendar before this story and are not caused by it.
What to watch next
The $AARD page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $AARD is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “beat” in the wording, with nothing on the bearish side to offset it. It was matched to $AARD. It carried $0.66, $0.22 and $73.9 million, shown as published and not recalculated. The preview above is the publisher's own wording.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 11, 2026. $AARD has moved -83.71% ($6.57 to $1.07). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.